Uncategorized
Alimera signs agreement with MEAgate to distribute Iluvien in Middle East
Alimera Sciences B.V., a subsidiary of Alimera Sciences, has signed an agreement with MEAgate International FZLLC to distribute Iluvien to treat diabetic macular edema in several Middle Eastern countries.According to the terms of the agreement, MEAgate will open a scientific office for Alimera in the Middle East to support regulatory, medical affairs, and sales and marketing operations, a press release said.